Tesamorelin

Tesamorelin is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH), studied for its ability to stimulate the body’s natural production of growth hormone. It has gained significant attention in research focused on fat metabolism, body composition, and metabolic health, particularly in relation to visceral fat reduction.

Tesamorelin works by signaling the pituitary gland to increase endogenous growth hormone (GH) production, which in turn influences several key metabolic processes.

Key research areas include:

• Reduction of visceral adipose tissue (abdominal fat)

• Support for lean body mass preservation

• Increased lipolysis (fat breakdown)

• Improved metabolic function and nutrient partitioning

• Influence on IGF-1 production and GH axis activity

Tesamorelin has been explored for broader effects on:

• Growth hormone and IGF-1 regulation

• Metabolic health and insulin dynamics

• Potential improvements in lipid profiles

• Supporting lean tissue retention during fat loss phases

One of the defining characteristics of Tesamorelin research is its specificity:

• Greater impact on visceral fat vs. subcutaneous fat

• Supports a leaner, more defined physique profile

• May assist in maintaining muscle while reducing fat mass